• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 2.00% Nasdaq Up 1.66%

    More On PTI

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Proteostasis Therapeutics, Inc. (PTI)

    -NasdaqGM
    6.18 Down 0.46(6.93%) Feb 12, 4:00PM EST
    Prev Close:6.64
    Open:6.55
    Bid:6.12 x 100
    Ask:6.14 x 200
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:5.85 - 6.55
    52wk Range:5.27 - 8.00
    Volume:191,556
    Avg Vol (3m):1,151,050
    Market Cap:37.54M
    P/E (ttm):N/A
    EPS (ttm):-3.77
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):9.18
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Proteostasis Therapeutics, Inc., a biopharmaceutical company, develops therapeutics to treat protein conformational diseases. The company offers disease-modifying therapeutics for cystic fibrosis; and also develops treatments for diseases caused b... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback